UA46083C2 - Застосування похідних гідроксамової кислоти для уповільнення процесів старіння шкіри, косметична композиція та спосіб косметичної обробки шкіри - Google Patents

Застосування похідних гідроксамової кислоти для уповільнення процесів старіння шкіри, косметична композиція та спосіб косметичної обробки шкіри Download PDF

Info

Publication number: UA46083C2
Authority: UA; Ukraine
Prior art keywords: group; formula; hydroxamic acid; atom; acid
Prior art date: 1995-12-22

Application number

UA98073917A

Other languages

English (en)

Russian (ru)

Ukrainian (uk)

Inventor

Надь Петер Літераті

Надь Петер Литерати

Бєа Фаркаш

Агнеш Вадас

Original Assignee

Медгене Лімітед

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-22

Filing date

1996-12-20

Publication date

2002-05-15

1996-12-20 Application filed by Медгене Лімітед filed Critical Медгене Лімітед

2002-05-15 Publication of UA46083C2 publication Critical patent/UA46083C2/uk

Links

239000002253 acid Substances 0.000 title claims abstract description 43
239000000203 mixture Substances 0.000 title claims abstract description 35
238000000034 method Methods 0.000 title claims abstract description 21
239000002537 cosmetic Substances 0.000 title claims abstract description 19
230000008569 process Effects 0.000 title claims abstract description 8
NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title claims description 26
230000009759 skin aging Effects 0.000 title claims description 6
125000000217 alkyl group Chemical group 0.000 claims description 21
150000001875 compounds Chemical class 0.000 claims description 20
150000003839 salts Chemical class 0.000 claims description 18
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
229910052757 nitrogen Inorganic materials 0.000 claims description 12
239000004480 active ingredient Substances 0.000 claims description 11
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
239000000654 additive Substances 0.000 claims description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
230000000996 additive effect Effects 0.000 claims description 8
125000003277 amino group Chemical group 0.000 claims description 8
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 7
125000005843 halogen group Chemical group 0.000 claims description 7
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 6
229910052760 oxygen Inorganic materials 0.000 claims description 6
239000001301 oxygen Substances 0.000 claims description 6
125000004432 carbon atom Chemical group C* 0.000 claims description 5
125000000753 cycloalkyl group Chemical group 0.000 claims description 5
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 4
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims description 4
125000004430 oxygen atom Chemical group O* 0.000 claims description 4
239000000126 substance Substances 0.000 claims description 4
229910052717 sulfur Inorganic materials 0.000 claims description 4
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 3
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
125000002252 acyl group Chemical group 0.000 claims description 3
125000002947 alkylene group Chemical group 0.000 claims description 3
229910052736 halogen Inorganic materials 0.000 claims description 3
150000002367 halogens Chemical class 0.000 claims description 3
125000005842 heteroatom Chemical group 0.000 claims description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
239000011593 sulfur Substances 0.000 claims description 3
125000002723 alicyclic group Chemical group 0.000 claims description 2
125000000623 heterocyclic group Chemical group 0.000 claims description 2
229910052740 iodine Inorganic materials 0.000 claims description 2
125000001624 naphthyl group Chemical group 0.000 claims description 2
231100000252 nontoxic Toxicity 0.000 claims description 2
230000003000 nontoxic effect Effects 0.000 claims description 2
125000002755 pyrazolinyl group Chemical group 0.000 claims description 2
125000004076 pyridyl group Chemical group 0.000 claims description 2
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 2
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 2
239000013543 active substance Substances 0.000 claims 1
239000002671 adjuvant Substances 0.000 claims 1
125000003545 alkoxy group Chemical group 0.000 claims 1
229910052799 carbon Inorganic materials 0.000 claims 1
125000005936 piperidyl group Chemical group 0.000 claims 1
125000004434 sulfur atom Chemical group 0.000 claims 1
238000012876 topography Methods 0.000 claims 1
230000032683 aging Effects 0.000 abstract description 5
230000008807 pathological lesion Effects 0.000 abstract 1
239000006071 cream Substances 0.000 description 20
239000004615 ingredient Substances 0.000 description 14
-1 malondialdehyde Chemical class 0.000 description 13
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
241001465754 Metazoa Species 0.000 description 7
230000005855 radiation Effects 0.000 description 6
230000006378 damage Effects 0.000 description 5
239000000945 filler Substances 0.000 description 5
239000003921 oil Substances 0.000 description 5
235000019198 oils Nutrition 0.000 description 5
230000001575 pathological effect Effects 0.000 description 5
239000003925 fat Substances 0.000 description 4
235000019197 fats Nutrition 0.000 description 4
125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 4
229940060184 oil ingredients Drugs 0.000 description 4
206010040882 skin lesion Diseases 0.000 description 4
231100000444 skin lesion Toxicity 0.000 description 4
239000000243 solution Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
125000004429 atom Chemical group 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
235000014113 dietary fatty acids Nutrition 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
210000000981 epithelium Anatomy 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
239000000194 fatty acid Substances 0.000 description 3
229930195729 fatty acid Natural products 0.000 description 3
150000004665 fatty acids Chemical class 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
239000012528 membrane Substances 0.000 description 3
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
241000700198 Cavia Species 0.000 description 2
KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
230000005778 DNA damage Effects 0.000 description 2
231100000277 DNA damage Toxicity 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
102000016942 Elastin Human genes 0.000 description 2
108010014258 Elastin Proteins 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
239000005642 Oleic acid Substances 0.000 description 2
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
239000000460 chlorine Substances 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
201000009101 diabetic angiopathy Diseases 0.000 description 2
201000002249 diabetic peripheral angiopathy Diseases 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
150000002191 fatty alcohols Chemical class 0.000 description 2
238000009472 formulation Methods 0.000 description 2
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
150000002430 hydrocarbons Chemical group 0.000 description 2
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
230000003020 moisturizing effect Effects 0.000 description 2
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
230000001590 oxidative effect Effects 0.000 description 2
235000019271 petrolatum Nutrition 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
239000000600 sorbitol Substances 0.000 description 2
OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
208000008557 Actinic prurigo Diseases 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
108020004414 DNA Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
230000033616 DNA repair Effects 0.000 description 1
230000008265 DNA repair mechanism Effects 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
206010013786 Dry skin Diseases 0.000 description 1
208000029497 Elastoma Diseases 0.000 description 1
206010015150 Erythema Diseases 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
206010020565 Hyperaemia Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
206010023347 Keratoacanthoma Diseases 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
208000037273 Pathologic Processes Diseases 0.000 description 1
206010065159 Polychondritis Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
206010063493 Premature ageing Diseases 0.000 description 1
208000032038 Premature aging Diseases 0.000 description 1
208000004210 Pressure Ulcer Diseases 0.000 description 1
206010037549 Purpura Diseases 0.000 description 1
241001672981 Purpura Species 0.000 description 1
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
206010042496 Sunburn Diseases 0.000 description 1
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
201000006083 Xeroderma Pigmentosum Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
208000009621 actinic keratosis Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
125000003342 alkenyl group Chemical group 0.000 description 1
125000002714 alpha-linolenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])[H] 0.000 description 1
125000002886 arachidonoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
235000021302 avocado oil Nutrition 0.000 description 1
239000008163 avocado oil Substances 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
239000002876 beta blocker Substances 0.000 description 1
229940097320 beta blocking agent Drugs 0.000 description 1
230000003851 biochemical process Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
125000001589 carboacyl group Chemical group 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
230000030833 cell death Effects 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
229940119217 chamomile extract Drugs 0.000 description 1
235000020221 chamomile extract Nutrition 0.000 description 1
230000008859 change Effects 0.000 description 1
YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
229960003333 chlorhexidine gluconate Drugs 0.000 description 1
ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
238000006482 condensation reaction Methods 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
230000000254 damaging effect Effects 0.000 description 1
230000008260 defense mechanism Effects 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
230000037336 dry skin Effects 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
231100000321 erythema Toxicity 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
239000006260 foam Substances 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
239000012676 herbal extract Substances 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
229910052909 inorganic silicate Inorganic materials 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
230000003859 lipid peroxidation Effects 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
229940118019 malondialdehyde Drugs 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
230000035772 mutation Effects 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
239000007764 o/w emulsion Substances 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
230000009054 pathological process Effects 0.000 description 1
208000002440 photoallergic dermatitis Diseases 0.000 description 1
239000000049 pigment Substances 0.000 description 1
125000003386 piperidinyl group Chemical group 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
230000004224 protection Effects 0.000 description 1
230000009979 protective mechanism Effects 0.000 description 1
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
206010037844 rash Diseases 0.000 description 1
208000022064 reactive hyperemia Diseases 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000000979 retarding effect Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
230000037380 skin damage Effects 0.000 description 1
230000036560 skin regeneration Effects 0.000 description 1
235000010268 sodium methyl p-hydroxybenzoate Nutrition 0.000 description 1
239000007921 spray Substances 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
230000005748 tumor development Effects 0.000 description 1
150000004670 unsaturated fatty acids Chemical class 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1
229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
230000002792 vascular Effects 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
239000007762 w/o emulsion Substances 0.000 description 1
239000010497 wheat germ oil Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Birds (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Gerontology & Geriatric Medicine (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

UA98073917A 1995-12-22 1996-12-20 Застосування похідних гідроксамової кислоти для уповільнення процесів старіння шкіри, косметична композиція та спосіб косметичної обробки шкіри UA46083C2 (uk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU9503728A HUT78139A (hu)	1995-12-22	1995-12-22	Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
PCT/HU1996/000081 WO1997023198A1 (en)	1995-12-22	1996-12-20	A cosmetic composition and a method for reducing the ageing processes of skin

Publications (1)

Publication Number	Publication Date
UA46083C2 true UA46083C2 (uk)	2002-05-15

Family

ID=10987504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA98073917A UA46083C2 (uk)	1995-12-22	1996-12-20	Застосування похідних гідроксамової кислоти для уповільнення процесів старіння шкіри, косметична композиція та спосіб косметичної обробки шкіри

Country Status (16)

Country	Link
EP (2)	EP1025838B1 (de)
JP (2)	JP2001509129A (de)
KR (1)	KR19990076669A (de)
CN (2)	CN1207670A (de)
AT (1)	ATE237306T1 (de)
AU (1)	AU1167397A (de)
CA (1)	CA2240505A1 (de)
DE (1)	DE69627547T2 (de)
DK (1)	DK1025838T3 (de)
ES (1)	ES2197565T3 (de)
HU (1)	HUT78139A (de)
IL (2)	IL124984A0 (de)
PT (1)	PT1025838E (de)
RU (1)	RU2197954C2 (de)
UA (1)	UA46083C2 (de)
WO (1)	WO1997023198A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2813195B1 (fr) *	2000-08-29	2003-04-04	Serobiologiques Lab Sa	Utilisation d'extraits de la plante cassia alata dans des produits de soin
DE10240989A1 (de) *	2002-09-05	2004-03-11	Uwe Klewinghaus	Zusammensetzung und deren Verwendung als pharmazeutische oder kosmetische Formulierung zur äußerlichen Anwendung
HUP0401177A2 (en) *	2004-06-14	2007-09-28	N Gene Res Lab Inc	Pharmaceutical composition for increasing the mitochondrial genesis
HUP0500145A2 (en) *	2005-01-28	2006-11-28	Gene Res Lab N	Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1404481A (fr) *	1963-04-16	1965-07-02	Hoffmann La Roche	Procédé pour la préparation de nouveaux 3-éthers de la nu-(alpha, gamma-dihydroxy-beta, beta-diméthyl-butyryl)-propylamine
HU177578B (en) *	1976-08-27	1981-11-28	Chinoin Gyogyszer Es Vegyeszet	Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
HU184626B (en) *	1979-06-01	1984-09-28	Ferrokemia Ipari	Congesting cosmetics first of all hair-restorers
HU207988B (en) *	1988-10-20	1993-07-28	Biorex Kutato Fejlesztoe Kft	Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
RU2020927C1 (ru) *	1991-05-22	1994-10-15	Харитонова Галина Федоровна	Крем для защиты кожи от солнечных ожогов
TW233264B (de) *	1992-02-03	1994-11-01	Otsuka Pharma Co Ltd
RU2032677C1 (ru) *	1992-05-05	1995-04-10	Бристоль-Мейерз Сквибб Компани	Производные оксазола
RU2036637C1 (ru) *	1992-08-25	1995-06-09	Московская медицинская академия им.Сеченова	Косметическое средство для регенерации увядающей кожи (варианты)
RU2038070C1 (ru) *	1992-10-28	1995-06-27	Елена Юрьевна Хараламбус	Набор масок для лечения косметических недостатков кожи
HU222994B1 (hu) *	1995-11-02	2004-01-28	BIOREX Kutató és Fejlesztő Rt.	Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására

1995
- 1995-12-22 HU HU9503728A patent/HUT78139A/hu unknown
1996
- 1996-12-20 EP EP99123365A patent/EP1025838B1/de not_active Expired - Lifetime
- 1996-12-20 CA CA002240505A patent/CA2240505A1/en not_active Abandoned
- 1996-12-20 EP EP96942539A patent/EP0869771A1/de not_active Withdrawn
- 1996-12-20 DK DK99123365T patent/DK1025838T3/da active
- 1996-12-20 CN CN96199664A patent/CN1207670A/zh active Pending
- 1996-12-20 DE DE69627547T patent/DE69627547T2/de not_active Expired - Fee Related
- 1996-12-20 IL IL12498496A patent/IL124984A0/xx unknown
- 1996-12-20 AT AT99123365T patent/ATE237306T1/de not_active IP Right Cessation
- 1996-12-20 JP JP52344497A patent/JP2001509129A/ja active Pending
- 1996-12-20 RU RU99125652/14A patent/RU2197954C2/ru not_active IP Right Cessation
- 1996-12-20 KR KR1019980704781A patent/KR19990076669A/ko not_active Ceased
- 1996-12-20 ES ES99123365T patent/ES2197565T3/es not_active Expired - Lifetime
- 1996-12-20 PT PT99123365T patent/PT1025838E/pt unknown
- 1996-12-20 UA UA98073917A patent/UA46083C2/uk unknown
- 1996-12-20 WO PCT/HU1996/000081 patent/WO1997023198A1/en not_active Ceased
- 1996-12-20 IL IL132854A patent/IL132854A/en not_active IP Right Cessation
- 1996-12-20 AU AU11673/97A patent/AU1167397A/en not_active Abandoned
1999
- 1999-11-24 JP JP33302699A patent/JP3806277B2/ja not_active Expired - Fee Related
- 1999-11-30 CN CNB991243994A patent/CN1173692C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
RU2197954C2 (ru)	2003-02-10
JP3806277B2 (ja)	2006-08-09
HK1029943A1 (en)	2001-04-20
KR19990076669A (ko)	1999-10-15
CN1263762A (zh)	2000-08-23
PT1025838E (pt)	2003-09-30
JP2001509129A (ja)	2001-07-10
IL132854A (en)	2006-06-11
EP1025838B1 (de)	2003-04-16
AU1167397A (en)	1997-07-17
DK1025838T3 (da)	2003-08-11
EP0869771A1 (de)	1998-10-14
DE69627547T2 (de)	2003-12-24
ES2197565T3 (es)	2004-01-01
CN1173692C (zh)	2004-11-03
EP1025838A1 (de)	2000-08-09
CA2240505A1 (en)	1997-07-03
HUT78139A (hu)	2000-11-28
CN1207670A (zh)	1999-02-10
ATE237306T1 (de)	2003-05-15
HU9503728D0 (en)	1996-02-28
DE69627547D1 (de)	2003-05-22
IL124984A0 (en)	1999-01-26
WO1997023198A1 (en)	1997-07-03
JP2000302657A (ja)	2000-10-31

Publication	Publication Date	Title
JP2731705B2 (ja)	1998-03-25	化粧料組成物及び皮膚科用医薬組成物
DE69812519T2 (de)	2003-12-11	Resorcinderivate
KR920006902B1 (ko)	1992-08-22	외용제
EP1594455A1 (de)	2005-11-16	Kosmetische oder dermatologische zubereitungen mit einem gehalt an kreatin, kreatinin und/oder seinen derivaten in kombination mit sojabohnenkeimextrakten
RU2123325C1 (ru)	1998-12-20	Косметическая и/или дерматологическая композиция и способ борьбы с внутренним старением кожи
US6458371B1 (en)	2002-10-01	Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
DE19720339A1 (de)	1998-11-19	Wirkstoffe und Zubereitungen für die Hautaufhellung und zur Verhinderung der Hautbräunung
UA46083C2 (uk)	2002-05-15	Застосування похідних гідроксамової кислоти для уповільнення процесів старіння шкіри, косметична композиція та спосіб косметичної обробки шкіри
EP1414401A1 (de)	2004-05-06	Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen
US6884424B2 (en)	2005-04-26	Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
JPS6410492B2 (de)	1989-02-22
JPH0820512A (ja)	1996-01-23	メラニン産生抑制剤及び美白用皮膚外用剤
KR102829583B1 (ko)	2025-07-07	3,4,5-트리메톡시 신남산 에스테르 유도체 및 만노실에리트리톨 지질을 포함하는 피부 미백용 조성물
DE10002725A1 (de)	2001-07-12	Wirkstoffe und Zubereitungen für die Hautaufhellung und zur Verhinderung der Hautbräunung (skin whitening)
CA2290702C (en)	2003-08-05	Topical compositions and methods for reducing ageing processes of skin and treating pathological lesions of skin
AU745987B2 (en)	2002-04-11	A cosmetic composition and a method for reducing the ageing processes of skin
US5547678A (en)	1996-08-20	Compositions and methods for combating blemishes and/or ageing of the skin
JP2007106765A (ja)	2007-04-26	皮膚の脱色のためのｃ−グリコシド化合物の使用
KR100366677B1 (ko)	2003-03-31	피부 노화과정을 억제하는 화장 조성물 및 방법
JPH06172150A (ja)	1994-06-21	皮膚化粧料
DE102005022292A1 (de)	2006-11-16	Verwendung von Peroxidzersetzern in kosmetischen und pharmazeutischen Mitteln zur Behandlung der Haut
KR920003324B1 (ko)	1992-04-27	색백화장료
JPH08268862A (ja)	1996-10-15	光老化防止剤及びこれを含有する皮膚化粧料
JPH10194919A (ja)	1998-07-28	皮膚外用剤
HU223901B1 (hu)	2005-04-28	Készítmény, különösen a bőr öregedési folyamatának mérséklésére